Compound 11 ((E)-N-hydroxy-3-(1-(4-methoxyphenylsulfonyl)-1,2,3,4-tetrahydroquinolin-6-yl)acrylamide) is a novel HDAC inhibitor with cytotoxicity in a variety of human cancer cell lines [12]. Here, HDAC9 is linked to cancer.